COMPETITIVE STRATEGIES OF BIOTECHNOLOGY FIRMS: IMPLICATIONS FOR U.S. AGRICULTURE

The agricultural biotechnology industry has evolved from a focus on outstanding science to a more mature phase where firms focus on near-term products and building businesses. Understanding complex relationships and distribution channels and a global perspective are crucial to commercialization. Yet, leading-edge technology and early identification of key traits will be critical to developing superior products that ensure competitiveness in the marketplace. Monsanto is organizing around a life sciences model where seed, crop chemicals, pharmaceuticals, and food ingredient businesses will exploit mutual synergies driven by basic science and discovery.


Issue Date:
1997-07
Publication Type:
Journal Article
PURL Identifier:
http://purl.umn.edu/15540
Published in:
Journal of Agricultural and Applied Economics, Volume 29, Number 1
Page range:
117-122
Total Pages:
6




 Record created 2017-04-01, last modified 2017-08-23

Fulltext:
Download fulltext
PDF

Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)